LBRX — LB Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $350.11m
- $335.89m
Annual balance sheet for LB Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 43.3 | 28 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 45.6 | 28.9 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.023 | 4.16 |
| Other Long Term Assets | ||
| Total Assets | 45.7 | 33.5 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 2.61 | 8.11 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 4.16 | 13.8 |
| Redeemable Preferred Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 41.5 | 19.7 |
| Total Liabilities & Shareholders' Equity | 45.7 | 33.5 |
| Total Common Shares Outstanding |